AR102494A1 - METHODS TO TREAT EYE DISEASES - Google Patents
METHODS TO TREAT EYE DISEASESInfo
- Publication number
- AR102494A1 AR102494A1 ARP150103539A ARP150103539A AR102494A1 AR 102494 A1 AR102494 A1 AR 102494A1 AR P150103539 A ARP150103539 A AR P150103539A AR P150103539 A ARP150103539 A AR P150103539A AR 102494 A1 AR102494 A1 AR 102494A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- eye diseases
- treat eye
- treatment
- burden
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000030533 eye disease Diseases 0.000 title 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Método para reducir la carga del tratamiento para pacientes que padecen un trastorno neovascular intraocular, donde el método comprende administrar una cantidad terapéuticamente efectiva del antagonista del VEGF en una administración de la dosificación que incluye intervalos de tratamiento de 8 y/o 12 semanas.Method for reducing the burden of treatment for patients suffering from an intraocular neovascular disorder, where the method comprises administering a therapeutically effective amount of the VEGF antagonist in a dosage administration that includes treatment intervals of 8 and / or 12 weeks.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462076770P | 2014-11-07 | 2014-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102494A1 true AR102494A1 (en) | 2017-03-01 |
Family
ID=58688557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103539A AR102494A1 (en) | 2014-11-07 | 2015-11-02 | METHODS TO TREAT EYE DISEASES |
| ARP150103621A AR102572A1 (en) | 2014-11-07 | 2015-11-06 | FORMULATION OF STABLE PROTEIN SOLUTION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103621A AR102572A1 (en) | 2014-11-07 | 2015-11-06 | FORMULATION OF STABLE PROTEIN SOLUTION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY |
Country Status (1)
| Country | Link |
|---|---|
| AR (2) | AR102494A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109475597A (en) * | 2017-04-26 | 2019-03-15 | 参天堂制药(株) | Ophthalmic pharmaceutical composition |
-
2015
- 2015-11-02 AR ARP150103539A patent/AR102494A1/en unknown
- 2015-11-06 AR ARP150103621A patent/AR102572A1/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109475597A (en) * | 2017-04-26 | 2019-03-15 | 参天堂制药(株) | Ophthalmic pharmaceutical composition |
Also Published As
| Publication number | Publication date |
|---|---|
| AR102572A1 (en) | 2017-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017005875A (en) | Methods for treating ocular diseases. | |
| MX2024010140A (en) | NEW METHODS. | |
| BR112016000546A2 (en) | methods to treat or prevent eye conditions | |
| CY1122143T1 (en) | DRUG COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR, AND OPTIONALLY A PI3K-ALPHA INHIBITOR | |
| BR112017002637A2 (en) | methods to treat or prevent eye conditions | |
| MX2015015228A (en) | TREATMENT IN THE TREATMENT OF MYELINIZATION DISEASES. | |
| EA201691872A1 (en) | HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS | |
| PH12017502142A1 (en) | Tetrasubstituted aklene compounds and their use | |
| EA201791199A1 (en) | METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
| EA201691454A1 (en) | COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING | |
| EA201890891A1 (en) | BIOMARKERS ASSOCIATED WITH INTERLEYKIN-33 DISEASES, AND THEIR APPLICATION | |
| BR112017018964A2 (en) | use of plinabulin and methods to treat brain tumor | |
| MX2017009694A (en) | Anti-cd40l antibodies and methods for treating cd40l-related diseases or disorders. | |
| EA201591290A2 (en) | CRENOLOLIBS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS RELATED TO FLT3 MUTATION | |
| CR20150637A (en) | TREATMENT OF MIOPATIC AND NEURODEGENERATIVE DISEASES BY PROTEIN AGGREGATION THROUGH PARENTERAL ADMINISTRATION | |
| PH12017500933A1 (en) | Sublingual administration of riluzole | |
| EP4324454A3 (en) | Cross-linking agents and associated methods | |
| PH12017500934B1 (en) | Sublingual formulation of riluzole | |
| MD4710B1 (en) | Anamorelin-based therapeutic treatments | |
| EA201991175A1 (en) | THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS | |
| MX2019009586A (en) | Compositions and methods for treating disease associated with permeability of intestinal epithelium. | |
| EA201691656A2 (en) | THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS | |
| EA201892265A1 (en) | METHODS OF TREATMENT OF OPHTHALMIC DISEASES | |
| CL2019000625A1 (en) | Fxr agonist combination. | |
| MX389282B (en) | COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |